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Purpose: To evaluate the efficacy and safety of fibrin bioadhesive in conjunctivolimbal autograft surgery for 
primary pterygium.
Methods: Thirty-six eyes in 34 patients were reviewed with nasal primary pterygium who were treated with 
pterygium excision with superior conjunctivolimbal transplantation with fibrin bioadhesive. Surgical durations 
were recorded and the patients were followed up on the first day after surgery and then at 1, 2, 4, 8 and 
12 weeks postoperatively. The graft-recipient site attachments were examined and subjective symptoms of 
patients were recorded at every follow-up examinations.
Results: The mean patient age was 57.9±10.1 (ranging from 33 to 83) years. The mean follow-up period 
was 22.05±5.78 weeks. The mean surgery time was 18.04±5.65 minutes. The subjective symptoms (pain, 
foreign body sensation, tearing and discomfort) disappeared in 23 of 36 eyes (64%) in one week after 
surgery, and all discomforts subsided within two weeks after surgery in all patients. The conjunctivolimbal 
autograft was correctly positioned and fixed in 34 of 36 eyes (94.4%) throughout the follow-up period. Graft 
dehiscence was seen in two eyes (5.6%), one eye was treated with remedial sutures, and the other eye 
showed a spontaneous healing without remedial sutures. Transient graft edema occurred in four eyes 
(11.2%) but subsided spontaneously within a month. There were no cases of pterygium regrowth or 
complications due to the fibrin bioadhesive.
Conclusions: The use of fibrin bioadhesive in conjunctivolimbal autograft surgery in primary pterygium 
simplifies surgical techniques, shorten surgical duration, and produce less postoperative subjective 
symptoms . Therefore, the fibrin bioadhesive is a safe and effective tool to attach conjunctivolimbal autograft 
in primary pterygium surgery.
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Pterygium, a common ocular surface disorder, is a triangular 
-shaped growth of bulbar conjunctival epithelium and 
hypertrophied subconjunctival connective tissue in the medial 
and lateral palpebral fissure encroaching onto the cornea. 
Well-known risk factors are genetic predisposition, immune 
mechanism and chronic environmental irritations including 
ultraviolet rays, wind, and dusts, even though the etiology 
remains not clearly known.
1 The prime challenge of 
pterygium surgery is prevention of recurrence. The reports of 
recurrence rate have discrepancies, but the recurrence rate of 
primary pterygium after simple excision is reportedly 
25-45%.
2 Subsequently, some techniques currently used to 
prevent recurrence of pterygium are beta-radiation, excimer 
laser, argon laser, Thio-Tepa and anti-metabolite drugs, 
conjunctivolimbal autograft and amniotic membrane graft.
3-10 
The recurrence of pteygium is closely associated with 
corneo-limbal stem cell deficiency. The recurrent pterygium 
is usually associated with more severe conjunctival inflam- 
mation, corneal involvement, and adhesion with surrounding 
tissue than the primary pterygium, causing conjunctival 
injection, ocular pain, ocular movement dysfunction and 
diplopia.
Anti-metabolites including mitomycin C (MMC) were 
introduced to prevent the recurrence of pterygium. The use 
of anti-metabolites is restricted by several complications 
including various ocular surface diseases, secondary glaucoma, 
and cataract.
7
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Grade 1 (atrophic) Episcleral vessels under the body of the pterygium not obscured and clearly distinguished
Grade 2 (intermediate) All other pterygia not falling into grade 1 or 3
Grade 3 (fleshy) Episcleral vessels totally obscured by the body of pterygium
Table 1.  Pterygium grading system suggested by Tan et al.
11
autograft was reported to be the most effective method of 
lowering recurrence rate (2~9%) and occurrence of 
complications.
9-11 
However, the current method of attaching conjunctival or 
conjunctivolimal autograft by means of suturing presents 
several disadvantages, including complicated surgical 
techniques, prolonged operating time, prolonged postope- 
rative patient discomfort, and suture-related potential 
complications. Moreover, many Asian patients, including 
Koreans, have narrower interpalpebral fissures than 
Caucasians or Africans, which can make suturing procedures 
more difficult to attach the conjunctival or conjunctivolimbal 
autograft.
Fibrin tissue bioadhesives which mimics the natural 
fibrinogen and thrombin reaction are used on various 
ophthalmologic surgeries for tissue adhesion, blood 
coagulation and wound healing.
12-18 The use of tissue 
bioadhesives as an alternative means of attaching the grafts 
may shorten operating time, improve postoperative 
discomfort, and possibly avoid suture-related complications.
16-18
The purpose of this study is to reveal the efficacy and 
safety of using fibrin bioadhesive (Tissucol Duo Quick
®, 
Baxter AG, Vienna, Austria) in place of sutures during 
conjunctivolimbal autograft surgery for primary pterygium in 
Korean patients.
Materials and Methods 
From March to October, 2006, 36 eyes in 34 patients (a 
consecutive case series) with nasal primary pterygium were 
treated with superior conjunctivolimbal transplant with fibrin 
glue (Tissucol Duo Quick
®) at Cheil Eye Hospital by a single 
surgeon. Informed consent was obtained from all patients. 
Before surgery, a comprehensive investigation was taken 
including patient age, gender, medical and ocular history. 
Snellen visual acuity measurement, non-contact tonometry 
(Canon TX-10 tonometer), slit-lamp examination, and anterior 
segment photography were performed preoperatively. Patients 
with ocular pathology other than refractive error such as 
history of previous ocular surgery or trauma and known 
hypersensitivity to any component of fibrin bioadhesive were 
excluded. 
Pterygium Grading
The pterygia were graded according to the system used by 
Tan et al.
11: grade 1 (atrophic), episcleral vessels under the 
body of the pterygium are not obscured and clearly 
distinguished; grade 3 (fleshy), episcleral vessels totally 
obscured; and grade 2 (intermediate), and all other pterygia 
not falling into these 2 grades (Table 1).
Fibrin Bioadhesive
Fibrin glue (Tissucol Duo Quick
®) is a tissue adhesive 
composed of two components which mimics the natural fibrin 
formation. One component contains fibrinogen mixed with 
coagulation factor 13 and aprotinin, and the other component 
contains thrombin and calcium chloride. Once the two 
components are mixed, fibrinogen is converted into fibrin by 
the action of thrombin; fibrin is then cross-linked by 
coagulation factor 13 to create a firm fibrin network. 
Aprotinin from bovine lungs prevent rapid fibrinolysis.
Surgical Technqiue 
A single surgeon (Y.J. Park) performed all surgeries 
according to the same surgical techniques (Fig. 1). After 
instillation of topical proparacaine HCl (Alcaine
®, Alcon 
Laboratories, Fort Worth, TX), the involved eye underwent 
standard ophthalmologic sterile preparation and draping. 
Then, the eye was exposed for operation using lid speculum. 
A lidocaine–epinephrine solution (Xylocaine
® 2%, Astra- 
Zeneca, Sweden) was injected into the pterygium head to 
balloon out the conjunctiva. Blunt and sharp dissection was 
performed to separate the pterygium from the underlying 
sclera and surrounding conjunctiva. The pterygium head and 
surrounding atrophic conjunctival edges were excised and 
sclera was exposed. MMC was not used during or after the 
operation.
Before harvesting the free conjunctivolimbal autograft 
from superior limbus, the lidocaine-epinephrine solution was 
injected in to the donor conjunctiva to balloon out the area 
of the graft and separate it from the underlying Tenon’s 
capsule. The donor graft at superior limbus was excised with 
an additional 1.0 mm of length and width relative to the 
dimensions of the graft bed. By use of minimal manipulation 
with atraumatic conjunctival forceps and Vannas scissors, the 
conjunctiva was carefully dissected away from the Tenon’s 
capsule. Care was taken to prevent buttonholes and graft 
rollover. The dissected graft was flipped over the cornea, and 
then taking care that the palisades of Vogt was included in 
the graft, excision was made from limbal attachment. The 
free graft then was placed on top of the cornea and kept 
moist. 
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Fig. 1. Surgical procedures of conjunctivolimbal autograft using a fibrin adhesive (Tissucol Duo Quick®) in pterygium surgery.
(A) Pre-operative fleshy nasal pterygium. (B) The pterygium head was excised, the conjunctiva allowed to retract, and the 
subconjunctival fibrovascular tissue excised en bloc. (C) Superior conjunctivolimbal autograft was flipped over the cornea and the 
limbal attachment, and them the head of the palisades of Vogt was cleaned with a blade. (D) Conjunctivolimbal autograft kept placed
over the cornea. The graft was rotated toward the defect site, spreading the conjunctiva out, being mindful of orienting the limbal stem
cell population toward the limbus. (E) The fibrin glue was applied over the bare sclera and conjunctivolimbal autograft; A drop of
fibrinogen solution was placed on the bare sclera and a drop of thrombin solution was placed conjunctivolimbal autograft. 
(F) Conjunctivolimbal autograft spread over the bare sclera with the edges bonded to the surrounding health conjunctiva by using 
McPherson forceps. 
Fig. 2. The photograph anterior segment on day 1 after 
pterygium excision and superior conjunctivolimbal autograft 
attached with fibrin glue. Note the relatively low inflammatory 
appearance of the eye, well-positioned graft and reestablishment
of the normal limbal architecture.
sclera and spread out with a needle cannula. Thrombin 
solution was applied on the donor graft surface placed on top 
of the cornea. The graft coated with thrombin solution was 
then immediately flipped over and spread out onto the bare 
sclera coated with fibrinogen solution by using two 
McPherson forceps, and soon thrombin and fibrinogen 
reacted to seal the donor graft to bare sclera. Care was taken 
to ensure that the limbal stem cell population was oriented 
toward the limbus and the sides of the graft were opposed 
to the edges of the recipient conjunctiva. After a drying 
period of 5 minutes, the redundant margins of the graft were 
excised with Vannas scissors and the lid speculum was 
removed.
Neomycin sulfate/Polymyxin B sulfate/Dexamethasone 
ointment (Maxitrol
® ointment, Alcon Laboratories, Fort 
Worth, TX) was applied to the involved eye and a pressure 
patch and a eye shield was kept on for 24 hours (Fig. 2). 
Prednisolone acetate 1% (Pred-forte
®, Allergan Inc., Irvine, 
CA) and 0.5% levofloxacin (Cravit
® ophthalmic solution, 
Santen, Japan) eyedrops were applied 4 times daily for one 
month after the surgery.Korean J Ophthalmol Vol.22, No.3, 2008
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Number of eyes (patients) 36 eyes (34 patients)
Age (year) 57.9±10.1
Sex (M/F)  13/23
Pterygium grade (T1/T2/T3)* 0/12/24
Operation duration (minute) 18.0±5.7
Follow-up duration (week) 22.0±5.8
* The pterygia were graded according to the system used by 
Tan et al.
11
Table 2. Demographic charatacteristics of subjects 
(mean±SD)
Fig. 3. Left column (A, B, C, D, E, F): Images of preoperative fleshy grade 3 nasal primary pterygium. Right column (G, H, I, J,
K, L): Images of the conjuntivolimbal autograft of the same patients on 12 weeks after surgery. Well-positioned graft and 
reestablishment of the normal limbal architecture are observed with no signs of recurrence in all subjects.
Surgical Results Evaluation
To evaluate the efficacy of using fibrin bioadhesive in 
place of sutures during conjunctivolimbal autograft surgery 
for primary pterygium, operating time was recorded, the 
graft-recipient site attachment was observed and the 
subjective symptoms of patients were questioned in the 
postoperative follow-ups over 3 months. In order to assess 
the safety of this procedure, occurrence of complication was 
observed during follow-up examinations. 
Operating time was measured starting from the placement 
of the lid speculum to its removal at the end of the surgery. 
Graft survival was defined as an intact graft by the fourth 
week after surgery, and graft failure was defined as the 
absence of the graft by the fourth week. Recurrence was 
defined as any growth of fibrovascular tissue into the cornea 
by slit lamp examination.
The patients were followed up on the first day after 
surgery and then on weeks 1, 2, 4, 8 and 12. Inquiries were 
made regarding the presence and duration of subjective 
symptoms including pain, foreign body sensation, tearing, 
and discomfort, at every follow-ups. Additionally, Snellen 
visual acuity measurement, non-contact tonometry (Canon 
TX-10 tonometer), slit-lamp examination, and anterior 
segment photography were performed. A slit-lamp 
examination was performed at every visit to monitor 
autograft-bed integrity and development of possible 
complications.
Results
Of the 34 patients, 13 were male (38%) and 21 were 
female (62%). The mean patient age was 57.9±10.1 (SD) 
years (33-83 years). Of 36 eyes, 13 eyes were pterygium 
grade 2, and 24 eyes were grade 3 according to the grading 
system used by Tan et al.
11 (Table 2)
All patients completed the 3-month follow-up period. The 
mean follow-up time was 22.05±5.78 (SD) weeks (Table 2). 
The mean surgery time was 18.04±5.65 (SD) minutes. One 
week after surgery, subjective symptoms including pain, 
foreign body sensation, tearing and discomfort had 
disappeared in 23 of 36 (64%) cases and all subjective 
symptoms subsided within two weeks for all cases. HH Kim, et al. CONJUNCTIVAL AUTOGRAFT WITH BIOADHESIVE IN PTERYGIUM 
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A  B 
Fig. 4. (A) Mild shrinkage (between arrows) of the conjunctivolimbal autograft and recipient conjunctiva was noted 2 weeks after 
surgery: Secondary epithelialization and spontaneous closure of the wound gap occurred in one week. (B) Transient edema (arrows)
of conjunctivolimbal autograft 2 weeks after surgery: Spontaneous resolution occurred in one month. 
In 34 of 36 (94.4%) cases, the conjunctivolimbal autograft 
was observed to be correctly positioned and fixed in all the 
follow-up exams (Fig. 2, 3). Graft dehiscence was observed 
in two eyes (5.6%), one eye was given remedial sutures, and 
the other eye showed spontaneous healing without remedial 
sutures after a week. Transient graft edema occurred in four 
eyes (11.2%) but spontaneously subsided within a month 
(Fig. 4). There were no cases of pterygium regrowth or 
complications due to the fibrin bioadhesive during the 
follow-up period.
Discussion
Preventing pterygium recurrence is the main concern of 
pterygium surgery. The current major methods to prevent 
recurrence include use of MMC, conjunctival autografting, 
and amniotic membrane grafting.
19 The meta-analysis of 
pterygium recurrence after surgery reported by Sanchez- 
Thorin et al.
10 concluded that simple bare sclera resection 
alone is associated with 6 times higher odds of pterygium 
recurrence when MMC was used compared with conjunctival 
autograft, and 25 times higher odds of recurrence if MMC 
was not used. The authors, therefore, recommended that 
simple bare sclera excision should not be encouraged as a 
method of primary pterygium removal.
10 Although the 
intraoperative use of MMC is effective in preventing 
pterygium recurrence, the use of MMC can be associated 
with sight-threatening complications such as corneoscleral 
melt, cataract, uveitis, secondary glaucoma, and symble- 
pharon.
3,7-10
According to several scientific papers so far, conjunctival 
autografting results in lower pterygium recurrence rates when 
compared with bare sclera excision
9-11,20-27 and it is also 
associated with fewer complications compared to use of 
MMC.
20 Only one case of necrotizing scleritis has been 
reported, and that case was successfully treated with steroid 
treatment.
21 But, conjunctival autografting leaves conjunctival 
defects and adhesions due to fibrosis on the donor site, 
adding to the technical difficulty of another ocular surgeries, 
especially glaucoma surgery.
2.22 
Due to these problems, amniotic membrane transplantation 
has been suggested a replacement for conjunctival auto- 
grafting in several studies. Amniotic membrane is the 
innermost layer of fetal membrane composed of thick 
basement membrane and monolayer epithelium. The amniotic 
membrane functions as a barrier to protect fetus from the 
maternal infection and immune mechanisms. In addition, 
amniotic membrane transplantation causes no rejections.
28 
The basement membrane of amniotic membrane promotes the 
differentiation and migration of epithelial cells and reinforce 
the attachment of basal epithelial cells.
29 Several growth 
factors and anti-proteolytic factors from aminiotic membrane 
suppress the death and apoptosis of corneal surface cells;
30 
hence, it is used for the treatment of various ocular surface 
diseases. But in reality, amniotic membrane transplantation 
showed no reduction of recurrences in pterygium surgery 
compared to simple bare sclera technique. Amniotic 
membrane transplantation also had higher recurrence rate of 
pterygia compared to conjunctival autografting according to 
several studies.
9,19,26,31
As stated, conjunctival autografting is safe and clearly 
effective method in preventing pterygium recurrence, but in 
addition to the donor site conjunctival defects, the technical 
difficulty of attaching the autograft and prolonged operation 
time with suturing can be a challenge for many 
surgeons.
11,20-22  Furthermore, suture use is associated with Korean J Ophthalmol Vol.22, No.3, 2008
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Table 3. Comparison of surgical duration with other studies
Study Surgical technique used to attach 
conjunctival autograft
Surgial duration: 
Average (±SD) (minute)
Korany et al.
17 (Vicryl 7-0 suture)
(Fibrin bioadhesive)
18.5*
 9.7*
Harvey et al.
18 (Nylon 10-0 suture)
(Fibrin bioadhesive)
67.0±3.6
†
27.8±1.0
†
This study (Fibrin bioadhesive) 18.0±5.7
†
* Definition of surgical duration: “from the first incision until the removal of lid speculum”; 
† Definition of surgical duration: “from 
the placement of lid speculum to its removal at the end of surgery”.
Table 4. Comparison of postoperative subjective symptoms with other studies
Study
Surgical technique used to attach 
conjunctival (or conjuctivolimbal) 
autograft
The time interval when subjective symptoms disappeared 
in all the patients from the operation
Pain Foreign body 
sensation
Ocular 
discomfort Tearing
Korany et al.
17* (Vicryl 7-0 suture)
(Fibrin bioadhesive)
Over
1 week
Over
1 week
-
-
-
-
-
-
Harvey et al.
18 (Nylon 10-0 suture) 4 weeks Over
4 weeks
Over
4 weeks
Over
4 weeks
(Fibrin bioadhesive) 2 weeks 2 weeks 2 weeks 2 weeks
This study (Fibrin bioadhesive) 2 weeks 2 weeks 2 weeks 2 weeks
* The study was confined to postoperative pain evaluation during the first week after surgery.
patient discomfort (foreign body sensation, pain, discomfort, 
and tearing) and minor complications such as dellen ulcer, 
symblepharon, and graft dehiscence.
18
The transplantation of autologous conjunctiva can be 
divided into the simple conjunctival autograft and the 
conjunctivolimbal autograft including the corneal limbus. 
Guler et al.
23 reported a 13.3% recurrence rate in the seven 
cases followed for 14 to 24 months after conjunctivolimbal 
autografting in recurrent pterygium. The authors hypothesized 
the merit of conjunctivolimbal autografting including palisades 
of Vogt superior to simple conjunctival autografting in 
histologic structure reconstruction. Polute et al.
24 reported the 
efficacy of conjunctivolimbal autografting in preventing the 
recurrence of pterygia the first several years after long-term 
follow-up study over an average 44.97 months. Kim et al.
22 
reported a 1.9% recurrence rate 15 months after 
conjunctivolimbal autografting without MMC use in patients 
under age 40 with primary pterygium. Ahn et al.
25 reported 
no recurrences for 5 to 16 months after conjunctivolimbal 
autografting combined with the use of MMC in 10 cases of 
recurrent pterygium. This study also showed no recurrence of 
pterygium for 22.0±5.8 weeks follow-up after conjunctivo- 
limbal autografting including the palisades of Vogt. Despite 
the relative brevity of follow-up period, there was no 
recurrence of pterygium and no differences in recurrence rate 
according to the pterygium grade. Nevertheless, more studies 
are required to prove clinical merits of superiority of 
conjunctivolimbal autografting in lowering recurrence of 
pterygium to simple conjunctival autografting in tissue 
reconstruction.
Biologic adhesives, such as fibrin glue, can be an 
alternative method of conjunctival or conjunctivolimbal graft 
attachment that may produce fewer complications and less 
postoperative discomforts. Fibrin glue has previously been 
used in ophthalmology for conjunctival wound closure, 
cataract surgery, oculoplastic and orbital surgery, repair of 
leaking glaucoma filtering blebs, lamellar keratoplasty, and 
attachment of amniotic membrane patch.
12-18
Cohen and MacDonald
16 have reported the utility of an 
organic tissue adhesive (Tisseel
®, Baxter, Vienna, Austria) 
used to reduce the number of sutures needed for attaching 
conjunctival grafts in pterygium surgery. Koranyi et al.
17 
reported a randomized clinical trial that demonstrated that 
fibrin glue (Tisseel
®) alone without suture can be used 
successfully to attach conjunctival autografts and at the same 
time reduce operating time and postoperative discomforts 
compared with vicryl 7-0 sutures. Harvey et al.
18  also reported 
a randomized clinical trial to show the advantage of fibrin glue 
(Beriplast P
®, Aventis Behring, King of Prussia, PA) compared 
to suturing with nylon 10-0 for attaching conjunctival limbal 
autograft after pterygium excision. No sight-threatening 
complications developed, and none of the eyes lost vision in 
both series. Vicryl 7-0 sutures were compared with fibrin glue 
in the study by Koranyi et al.
17 and nylon 10-0 sutures HH Kim, et al. CONJUNCTIVAL AUTOGRAFT WITH BIOADHESIVE IN PTERYGIUM 
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compared with fibrin glue in the study by Harvey et al.
18 fewer 
postoperative symptoms were reported when fibrin glue was 
used for attaching conjunctival autografts in both studies.
17,24 
These reports showed that grafts attached with fibrin glue are 
better tolerated than grafts attached with suturing.
The advantages of using fibrin glue for attaching graft 
include ease of use, shorter operating times, and less 
postoperative discomforts. This study showed the reduction 
of mean operation time compared to that of conjunctival or 
conjunctivolimbal autografting attached with suturing in other 
studies (Table 3). A recent study by Ti et al. reported that 
the success rate of sutured conjunctival or conjunctivolimbal 
autograft can vary widely among different surgeons (range, 
5%–82%).
21 This variability was probably attributed to 
different surgical skill levels on learning curves among 
different ophthalmologists. Because the use of fibrin glue 
removes the need for the tedious suturing process, the 
learning curve can be shortened, and better results may be 
more consistently achieved despite differences in surgical 
expertise. Moreover, conjunctival or conjunctivolimbal 
autografting will be better accepted by the patients, because 
the use of fibrin glue produces less subjective symptoms as 
shown when comparing of postoperative subjective symptoms 
in other studies (Table 4). In this study, only inquiry 
regarding the presence and duration of subjective symptoms 
(foreign body sensation, pain, discomfort, and tearing) was 
made, not 5-point scale self-evaluation used in studies by 
Harvey et al.
18 due to the poor communication capability of 
a considerable numbers of the subjects. If 5-point scale 
self-evaluation was adopted in this study, more objective 
results could have been expected. 
All autografts were successfully attached in this study. 
Wound gapping in two eyes (5.6%) and transient graft edema 
in four eyes (11.2%) were observed, but no critical 
complications due to fibrin glue were observed including 
corneal defects, symblepharon, giant papillary conjunctivitis, 
granulation and contact dermatitis, previously proposed in 
other studies as possible complications.
11,20,22
There are some concerns regarding the safety of fibrin glue 
use, including potential for anaphylactic reaction and disease 
transmission.
18 None of the patients in this study had 
anaphylactic reactions. Adherence to strict manufacturing 
processes can prevent transmission of pathogens. 
In summary, fibrin glue is an effective and safe method 
for attaching conjunctival or conjunctivolimbal autografts 
during pterygium surgery. The use of fibrin glue can ease the 
surgical procedures, shorten operating times and produce less 
postoperative symptoms and discomfort. However, long-term 
postoperative studies are needed to confirm whether the rate 
of pterygium recurrence and other complications are affected 
by the use of fibrin glue.
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